Outcome Measures in Clinical Trials of Patients With Myasthenia Gravis

Myasthenia gravis (MG) is a heterogeneous disorder whose clinical presentation ranges from mild ocular deficits to severe widespread weakness. This variance poses a challenge when quantifying clinical deficits. Deficits and symptoms are quantified using standardized clinical scales and questionnaire...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomsen, Jan Lykke Scheel, Andersen, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793650/
https://www.ncbi.nlm.nih.gov/pubmed/33424747
http://dx.doi.org/10.3389/fneur.2020.596382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793650/
https://www.ncbi.nlm.nih.gov/pubmed/33424747
http://dx.doi.org/10.3389/fneur.2020.596382

Ejemplares similares